Dr. Binusha Moitheennazima , MD
Internal Medicine - Pulmonary Disease • Nacogdoches, TX
1209 N Mound St
Nacogdoches, TX 759614028
This profile restates public CMS/NPPES data; T-MedInfo gives no medical advice — consult a licensed professional, and call 911 for emergencies.
-
Dr. Binusha Moitheennazima is listed in NPPES under Internal Medicine - Pulmonary Disease.
-
NPI assigned on May 5, 2008; this date does not establish years in practice.
-
Published CMS data list 13,402 Original Medicare Part B services in 2024.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024. Published rows only; this is not a quality measure.
-
Published Part B service records, 2024:
- 99214 — Established patient outpatient office visit: 2,928 service units.
- 95004 — Test for allergy using allergenic extract: 2,016 service units.
- 94060 — Test to measure expiratory airflow and volume changes before and after medication administration: 1,107 service units.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024. Units differ by code; these are not visits or a measure of quality.
CPT® only copyright 2023 American Medical Association. All rights reserved. Service names are shortened from CPT Consumer Friendly Descriptors (CMS data, 2024). CPT notice
See all 26 records in the table · Guide: How to read Medicare Part B data
-
Published CMS data list 17,476 Medicare Part D prescriptions, including refills, in 2024.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024. Published rows only; this is not a quality measure.
-
Published Part D records, 2024:
- Montelukast Sodium — 2,134 prescription fills, including refills.
- Fluticasone Propionate — 775 prescription fills, including refills.
- Prednisone — 624 prescription fills, including refills.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024. Drug names come from pharmacy claims. Listing a drug here is not an endorsement or a recommendation.
See all 185 records in the table · Guide: How to read Medicare Part D prescriber data
-
More Medicare Part B services than 95% of clinicians listed under Internal Medicine - Pulmonary Disease in Texas (2024, 730 clinicians with data). Median for this group: 995. Middle half: 375 to 1,872.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024. Billing and prescribing volume is not a quality rating.
-
Medicare Part B services went from 16,991 in 2020 to 13,402 in 2024.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2020–2024.
Practice Location & Contact Primary Location
1209 N Mound St
Nacogdoches, TX 759614028
Matched by practice address or phone in NPPES. A shared address or phone does not confirm that this clinician works there.
CMS Doctors and Clinicians lists 2 distinct group names: Nacogdoches Pulmonary And Sleep Associates Pa; Texas Specialty Physicians. See the list
Source: CMS Doctors and Clinicians National Downloadable File, CMS release of October 2, 2026.
Listings do not confirm current availability, employment or a shared ownership network.
Medicare Profile & Education
Source: CMS Doctors and Clinicians National Downloadable File, CMS release of October 2, 2026
2000
What Public CMS Data Show
Internal Medicine - Pulmonary Disease: NPPES taxonomy is a reported classification, not proof of board certification.
Medicare patients
878 people with Original Medicare in 2024
It gives a sense of how many people with Medicare this clinician treated that year.
Source: CMS, Medicare Physician & Other Practitioners – by Provider, 2024.
Medicare-allowed amount
About $798,447 in 2024
The total amount Medicare approved for these services in 2024. It includes what Medicare paid and what patients or their other insurance owed, such as the deductible and coinsurance.
It shows the total cost of this clinician's Original Medicare services under Medicare's fee rules.
What this does not show: Medicare-allowed amount
This is not the clinician's income. Part of it can go to a clinic or group practice, staff, equipment or drugs. It is not the price you will pay.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024.
Paid by Medicare
About $621,872 in 2024
The part of the Medicare-allowed amount that Medicare itself paid in 2024, after patients' deductibles and coinsurance.
The gap between the allowed amount and this number is roughly what patients and their other insurance paid.
What this does not show: Paid by Medicare
This is not the clinician's income and not a measure of quality.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024.
30-day fills
20,840 standardized 30-day fills in 2024
CMS converts prescriptions to 30-day supplies so they can be compared. A 90-day prescription counts as about three 30-day fills.
What this does not show: 30-day fills
It is not a count of patients and not a measure of quality.
Part D drug cost
$2,436,772 in 2024
The total cost of these prescriptions in 2024, paid by Medicare drug plans, patients and other payers together.
It shows the total spending on drugs this clinician prescribed, not what any one patient paid.
What this does not show: Part D drug cost
A higher cost often reflects the type of medicines a specialty uses. It is not your out-of-pocket cost and not a measure of quality.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024.
Open Payments general payments, program year 2025
All general payments: $7,434.37 across 108 records.
By nature of payment
- Consulting Fee: $5,076.00 across 3 records.
- Food and Beverage: $2,234.38 across 103 records.
- Education: $123.99 across 2 records.
Reporting-company totals (3 largest of 14)
- AstraZeneca Pharmaceuticals LP: $5,744.75 across 23 records.
- GlaxoSmithKline, LLC.: $529.44 across 25 records.
- Verona Pharma, Inc.: $310.51 across 29 records.
A reported payment does not necessarily mean the financial relationship is improper and is not a measure of care quality. Clinicians can review and dispute these records.
Source: Calculated by T-MedInfo from CMS Open Payments general-payment records for program year 2025 (published June 30, 2026).
Years since graduation
26 years (graduated 2000)
CMS Doctors and Clinicians data list 2000 as the year this clinician finished professional school.
It tells you roughly how long ago the clinician finished school.
What this does not show: Years since graduation
It is not the number of years in practice, and more years does not mean better care.
Source: CMS Doctors and Clinicians National Downloadable File, CMS release of October 2, 2026.
NPI first issued
2008
The year this clinician's National Provider Identifier (NPI) was issued. An NPI is a unique 10-digit ID that US health care providers use for billing.
What this does not show: NPI first issued
NPIs have been issued only since 2005, so this year is not necessarily when the clinician started practicing.
Source: CMS NPPES NPI Registry.
Accepts Medicare assignment
CMS data list this clinician as accepting Medicare assignment. This means agreeing to take the Medicare-approved amount as full payment for covered services.
With Original Medicare, you usually pay only your deductible and coinsurance, and the office sends the claim to Medicare for you.
Medicare assignment applies to Original Medicare. It does not tell you whether the clinician is in a Medicare Advantage plan's network, accepts other insurance, or is taking new patients.
Source: CMS Doctors and Clinicians, CMS release of October 2, 2026; Medicare.gov, “Does your provider accept Medicare as full payment?”
Telehealth (some services)
Recent Medicare claims show this clinician provided some services by telehealth, such as a video or phone visit.
You may be able to have some visits without going to the office. Ask which visits can be done by telehealth.
What this does not show: Telehealth (some services)
It does not mean all services are offered by telehealth, or that telehealth is covered by your plan.
Source: CMS, Telehealth Indicator on Medicare Care Compare (fact sheet, January 2023); CMS Doctors and Clinicians, CMS release of October 2, 2026.
Enrolled in Medicare (PECOS)
Dr. Moitheennazima has a Medicare enrollment record in PECOS, the CMS system clinicians use to enroll so they can bill Medicare or order services for people with Medicare.
It does not show whether the clinician accepts assignment, is in your plan's network, or is taking new patients.
Source: CMS Medicare Fee-For-Service Public Provider Enrollment (PECOS); CMS Order and Referring file.
Can order Medicare-covered services
CMS lists Dr. Moitheennazima as eligible to order or refer Medicare Part B clinical laboratory and imaging services, durable medical equipment (DME) and home health services for people with Medicare.
Medicare pays for these items and services only when they are ordered by an eligible clinician.
What this does not show: Can order Medicare-covered services
It does not mean the clinician offers these services directly.
Source: CMS Medicare Fee-For-Service Public Provider Enrollment (PECOS); CMS Order and Referring file.
Compared with the same specialty in Nacogdoches and Texas
Billing and prescribing volume is not a quality rating.
Medicare Part B services
More Medicare Part B services than 95% of clinicians listed under Internal Medicine - Pulmonary Disease in Texas (2024, 730 clinicians with data). Median for this group: 995. Middle half: 375 to 1,872.
Too few clinicians listed under Internal Medicine - Pulmonary Disease in Nacogdoches have Medicare Part B data for 2024 to compare.
Medicare-allowed amount
A higher Medicare-allowed amount than 95% of clinicians listed under Internal Medicine - Pulmonary Disease in Texas (2024, 730 clinicians with data). Median for this group: $93,554. Middle half: $42,268 to $187,979.
Too few clinicians listed under Internal Medicine - Pulmonary Disease in Nacogdoches have Medicare Part B data for 2024 to compare.
Paid by Medicare
A higher Medicare payment amount than 95% of clinicians listed under Internal Medicine - Pulmonary Disease in Texas (2024, 730 clinicians with data). Median for this group: $72,493. Middle half: $32,672 to $145,098.
Too few clinicians listed under Internal Medicine - Pulmonary Disease in Nacogdoches have Medicare Part B data for 2024 to compare.
Medicare Part D prescriptions
More Part D prescriptions than 95% of clinicians listed under Internal Medicine - Pulmonary Disease in Texas (2024, 676 clinicians with data). Median for this group: 762. Middle half: 212 to 1,928.
Too few clinicians listed under Internal Medicine - Pulmonary Disease in Nacogdoches have Medicare Part D data for 2024 to compare.
Part D drug cost
A higher Part D drug cost than 90% of clinicians listed under Internal Medicine - Pulmonary Disease in Texas (2024, 676 clinicians with data). Median for this group: $429,867. Middle half: $72,110 to $1,195,672.
Too few clinicians listed under Internal Medicine - Pulmonary Disease in Nacogdoches have Medicare Part D data for 2024 to compare.
3 active clinicians are listed under Internal Medicine - Pulmonary Disease with a practice address in Nacogdoches, TX (984 in Texas).
Addresses are self-reported to NPPES and may be out of date.
CMS data by year
Changes may reflect reporting, coverage or privacy limits, not changes in care quality.
-
Medicare Part B services
Medicare Part B services decreased 21% from 16,991 in 2020 to 13,402 in 2024.
- 2020: 16,991
- 2021: 16,756
- 2022: 14,932
- 2023: 13,478
- 2024: 13,402
-
Medicare-allowed amount
Medicare-allowed amount decreased 25% from $1,067,356 in 2020 to $798,447 in 2024.
- 2020: $1,067,356
- 2021: $1,050,167
- 2022: $858,799
- 2023: $723,930
- 2024: $798,447
-
Paid by Medicare
Paid by Medicare decreased 26% from $838,118 in 2020 to $621,872 in 2024.
- 2020: $838,118
- 2021: $834,827
- 2022: $667,288
- 2023: $560,240
- 2024: $621,872
-
Medicare Part D prescriptions
Medicare Part D prescriptions increased 114% from 8,156 in 2020 to 17,476 in 2024.
- 2020: 8,156
- 2021: 7,965
- 2022: 9,407
- 2023: 15,654
- 2024: 17,476
-
30-day fills
30-day fills increased 101% from 10,353 in 2020 to 20,840 in 2024.
- 2020: 10,353
- 2021: 10,353
- 2022: 12,110
- 2023: 18,714
- 2024: 20,840
-
Part D drug cost
Part D drug cost increased 127% from $1,072,061 in 2020 to $2,436,772 in 2024.
- 2020: $1,072,061
- 2021: $1,246,386
- 2022: $1,572,483
- 2023: $2,387,674
- 2024: $2,436,772
-
Industry payments (Open Payments)
Industry payments (Open Payments) increased 610% from $1,047.66 in 2021 to $7,434.37 in 2025.
- 2021: $1,047.66
- 2022: $1,098.03
- 2023: $1,912.30
- 2024: $1,829.73
- 2025: $7,434.37
Sources: CMS Medicare Physician & Other Practitioners (2024), CMS Medicare Part D Prescribers (2024), CMS Open Payments (2025), CMS Doctors and Clinicians, CMS release of October 2, 2026, CMS NPPES NPI Registry. Specialty names follow the NUCC Health Care Provider Taxonomy.
Text: T-MedInfo · Report an error.
Pharma & Medical Device Financial Disclosures
Payments and other transfers of value that drug and medical device companies reported to CMS Open Payments
Program year 2025 (payments made January 1 – December 31, 2025): 108 records totaling $7,434.37.
| Manufacturer | Payment Nature | Product | Type | Amount ($) |
|---|---|---|---|---|
| AstraZeneca Pharmaceuticals LP |
Consulting Fee
Cash or cash equivalent
|
— | General | $1,692.00 |
| AstraZeneca Pharmaceuticals LP |
Consulting Fee
Cash or cash equivalent
|
FASENRA | General | $1,692.00 |
| AstraZeneca Pharmaceuticals LP |
Consulting Fee
Cash or cash equivalent
|
BREZTRI | General | $1,692.00 |
| AstraZeneca Pharmaceuticals LP |
Food and Beverage
In-kind items and services
|
BREZTRI | General | $135.00 |
| GlaxoSmithKline, LLC. |
Food and Beverage
In-kind items and services
|
NUCALA | General | $124.51 |
| JAZZ PHARMACEUTICALS INC. |
Education
In-kind items and services
|
XYWAV | General | $89.99 |
| AstraZeneca Pharmaceuticals LP |
Food and Beverage
In-kind items and services
|
BREZTRI | General | $87.84 |
| AstraZeneca Pharmaceuticals LP |
Food and Beverage
In-kind items and services
|
BREZTRI | General | $63.60 |
| Inspire Medical Systems, Inc. |
Food and Beverage
In-kind items and services
|
INSPIRE | General | $57.89 |
| AstraZeneca Pharmaceuticals LP |
Food and Beverage
In-kind items and services
|
BREZTRI | General | $54.56 |
| Viatris Specialty LLC |
Food and Beverage
In-kind items and services
|
YUPELRI | General | $44.03 |
| AstraZeneca Pharmaceuticals LP |
Food and Beverage
In-kind items and services
|
TEZSPIRE | General | $41.68 |
| AstraZeneca Pharmaceuticals LP |
Food and Beverage
In-kind items and services
|
BREZTRI | General | $40.92 |
| Inspire Medical Systems, Inc. |
Food and Beverage
In-kind items and services
|
INSPIRE | General | $34.10 |
| Amgen Inc. |
Education
In-kind items and services
|
— | General | $34.00 |
| JAZZ PHARMACEUTICALS INC. |
Food and Beverage
In-kind items and services
|
XYWAV | General | $31.74 |
| Boehringer Ingelheim Pharmaceuticals, Inc. |
Food and Beverage
In-kind items and services
|
OFEV | General | $31.01 |
| GlaxoSmithKline, LLC. |
Food and Beverage
In-kind items and services
|
NUCALA | General | $29.68 |
| ARS Pharmaceuticals Operations, Inc. |
Food and Beverage
In-kind items and services
|
NEFFY | General | $28.24 |
| Insmed, Inc. |
Food and Beverage
In-kind items and services
|
Arikayce | General | $27.36 |
| JAZZ PHARMACEUTICALS INC. |
Food and Beverage
In-kind items and services
|
XYWAV | General | $27.28 |
| GlaxoSmithKline, LLC. |
Food and Beverage
In-kind items and services
|
TRELEGY ELLIPTA | General | $27.23 |
| Boehringer Ingelheim Pharmaceuticals, Inc. |
Food and Beverage
In-kind items and services
|
OFEV | General | $26.72 |
| GlaxoSmithKline, LLC. |
Food and Beverage
In-kind items and services
|
NUCALA | General | $26.66 |
| JAZZ PHARMACEUTICALS INC. |
Food and Beverage
In-kind items and services
|
XYWAV | General | $26.23 |
(top 25 shown)
Source: CMS Open Payments, program year 2025, released June 30, 2026.
Performed Procedures & Service Volume
CPT® is a registered trademark of the American Medical Association. CPT codes, descriptions and other data only are copyright 2016–2023 American Medical Association. All rights reserved. Applicable FARS/HHSARS apply. Descriptions of CPT codes are the AMA's CPT Consumer Friendly Descriptors as published by CMS in the Medicare Physician & Other Practitioners – by Provider and Service data, 2017–2024; they are plain-language summaries, not for clinical coding or documentation. HCPCS Level II codes and descriptions are from CMS. Fee schedules, relative value units, conversion factors and/or related components are not assigned by the AMA, are not part of CPT, and the AMA is not recommending their use. The AMA does not directly or indirectly practice medicine or dispense medical services. The AMA assumes no liability for data contained or not contained herein.
| HCPCS Code | Services | Patients | Submitted Charge | Medicare Allowed |
|---|---|---|---|---|
|
99214
Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more
|
2,928 | 689 | $437.78 | $126.25 |
|
95004
Test for allergy using allergenic extract
|
2,016 | 28 | $13.48 | $3.46 |
|
94060
Test to measure expiratory airflow and volume changes before and after medication administration
|
1,107 | 512 | $133.32 | $38.04 |
|
95165
Professional service for preparation and provision of 1 or more antigens
|
1,104 | 23 | $53.10 | $14.29 |
|
J1100
Injection, dexamethasone sodium phosphate, 1 mg
|
1,100 | 124 | $10.00 | $0.11 |
|
J0696
Injection, ceftriaxone sodium, per 250 mg
|
824 | 106 | $4.20 | $0.46 |
|
95117
Professional service for multiple injections of allergen
|
545 | 34 | $38.89 | $11.89 |
|
96372
Injection of drug or substance under skin or into muscle
|
433 | 132 | $49.15 | $14.17 |
|
94729
Test to examine how well the lungs exchange gases
|
379 | 378 | $200.24 | $54.18 |
|
94726
Test to determine lung volumes using sensors
|
378 | 377 | $186.31 | $53.72 |
|
99212
Established patient office or other outpatient visit with straightforward medical decision making, if using time, 10 minutes or more
|
378 | 27 | $192.68 | $56.50 |
|
87804
Detection test by immunoassay with direct visual observation for influenza virus
|
281 | 97 | $52.00 | $16.22 |
|
99309
Subsequent nursing facility care with moderate level of medical decision making, per day, if using time, at least 30 minutes
|
263 | 50 | $354.73 | $107.22 |
|
95800
Sleep study including heart rate, breathing, and sleep time
|
251 | 93 | $550.66 | $133.25 |
|
99291
Critical care, first 30-74 minutes
|
233 | 68 | $949.97 | $212.86 |
|
99232
Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes
|
202 | 96 | $241.36 | $78.80 |
|
G0008
Administration of influenza virus vaccine
|
160 | 158 | $32.00 | $30.84 |
|
90661
Influenza vaccine, trivalent derived from cell cultures
|
157 | 157 | $40.00 | $35.88 |
|
G0506
Comprehensive assessment of and care planning for patients requiring chronic care management services (list separately in addition to primary monthly care management service)
|
143 | 141 | $210.95 | $62.69 |
|
87811
Detection test by immunoassay with direct visual observation for severe acute respiratory syndrome coronavirus 2 (covid-19)
|
141 | 97 | $125.00 | $40.55 |
|
99204
New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more
|
119 | 119 | $568.23 | $166.13 |
|
95811
Sleep study in sleep lab with continuous airway pressure (6 years or older)
|
115 | 115 | $2174.73 | $619.37 |
|
99223
Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes
|
45 | 43 | $670.81 | $170.03 |
|
95810
Sleep study in sleep lab (6 years or older)
|
42 | 42 | $2083.24 | $585.52 |
|
99306
Initial nursing facility care with high level of medical decision making, per day, if using time, 50 minutes or more
|
40 | 39 | $558.29 | $181.76 |
(top 25 shown)
Source: CMS Part B by Provider and Service, 2024; services under 11 beneficiaries omitted by CMS. Privacy limits
Submitted charges are billed amounts, not a price quote for your visit.
Medicare Part D Prescribing Profile & Medications
Medicare Part D prescriptions filled, including refills, in 2024.
| Brand Name | Generic Name | Prescriptions | Day Supply | Total Cost | Patients |
|---|---|---|---|---|---|
| Montelukast Sodium | Montelukast Sodium | 2,134 | 100,772 | $16,282.59 | 547 |
| Fluticasone Propionate | Fluticasone Propionate | 775 | 35,720 | $11,704.72 | 290 |
| Prednisone | Prednisone | 624 | 7,192 | $1,788.36 | 319 |
| Atorvastatin Calcium | Atorvastatin Calcium | 564 | 10,325 | $6,698.78 | 58 |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 540 | 18,090 | $385,465.44 | 149 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 496 | 13,878 | $14,815.68 | 244 |
| Furosemide | Furosemide | 420 | 10,726 | $2,393.45 | 68 |
| Potassium Chloride | Potassium Chloride | 370 | 9,067 | $6,215.90 | 58 |
| Trazodone Hcl | Trazodone Hcl | 370 | 12,348 | $3,819.91 | 74 |
| Levocetirizine Dihydrochloride | Levocetirizine Dihydrochloride | 322 | 14,398 | $2,742.44 | 88 |
| Amlodipine Besylate | Amlodipine Besylate | 316 | 7,462 | $3,105.95 | 39 |
| Levothyroxine Sodium | Levothyroxine Sodium | 310 | 6,762 | $3,660.17 | 44 |
| Gabapentin | Gabapentin | 297 | 6,330 | $3,392.39 | 36 |
| Eliquis | Apixaban | 293 | 4,984 | $103,375.59 | 30 |
| Advair Hfa | Fluticasone Propion/Salmeterol | 284 | 9,210 | $100,403.82 | 92 |
| Symbicort | Budesonide/Formoterol Fumarate | 274 | 10,773 | $83,994.81 | 84 |
| Sertraline Hcl | Sertraline Hcl | 239 | 4,599 | $2,739.38 | 21 |
| Breo Ellipta | Fluticasone/Vilanterol | 227 | 8,040 | $104,530.75 | 53 |
| Breztri Aerosphere | Budesonide/Glycopyr/Formoterol | 227 | 7,860 | $166,902.25 | 69 |
| Ventolin Hfa | Albuterol Sulfate | 217 | 4,955 | $14,301.27 | 92 |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 215 | 1,504 | $1,848.48 | 166 |
| Pantoprazole Sodium | Pantoprazole Sodium | 210 | 6,358 | $4,192.77 | 39 |
| Mirtazapine | Mirtazapine | 168 | 3,165 | $2,537.36 | 19 |
| Escitalopram Oxalate | Escitalopram Oxalate | 159 | 3,134 | $1,570.37 | 18 |
| Losartan Potassium | Losartan Potassium | 157 | 3,826 | $1,950.33 | 19 |
(top 25 shown)
Source: CMS Part D by Provider and Drug, 2024; rows below 11 claims omitted by CMS; volume isn’t quality. Privacy limits
Specialties & License Numbers Reported to NPPES
NUCC Taxonomy Code: 207RP1001X
An internist who treats diseases of the lungs and airways. The pulmonologist diagnoses and treats cancer, pneumonia, pleurisy, asthma, occupational and environmental diseases, bronchitis, sleep disorders, emphysema and other complex disorders of the lungs.
NUCC Taxonomy Code: 207RC0200X
An internist who diagnoses, treats and supports patients with multiple organ dysfunction. This specialist may have administrative responsibilities for intensive care units and may also facilitate and coordinate patient care among the primary physician, the critical care staff and other specialists.
NUCC Taxonomy Code: 207RS0012X
An Internist who practices Sleep Medicine is certified in the subspecialty of sleep medicine and specializes in the clinical assessment, physiologic testing, diagnosis, management and prevention of sleep and circadian rhythm disorders. Sleep specialists treat patients of any age and use multidisciplinary approaches. Disorders managed by sleep specialists include, but are not limited to, sleep related breathing disorders, insomnia, hypersomnias, circadian rhythm sleep disorders, parasomnias and sleep related movement disorders.
Medicare (PECOS) Enrollment & Ordering Eligibility
Source: CMS PECOSPRACTITIONER - PULMONARY DISEASE
I20100922000171
TX
1759457468
Sources: CMS Provider Enrollment and Order and Referring. Medicare enrollment is a billing status, not an accreditation or quality rating.
Medicare Group Practice Enrollments
Source: CMS Doctors and Clinicians National Downloadable File, CMS release of October 2, 2026
Nacogdoches Pulmonary And Sleep Associates Pa
1209 N Mound St, Nacogdoches, TX 759614028
Phone: 9365854646
Texas Specialty Physicians
2900 S Loop, Palestine, TX 758016958
Phone: 9037311000
Clinicians Sharing This Practice Address or Phone
Clinicians sharing this NPPES address, phone or fax; a shared contact does not mean they work together.
Nurse Practitioner
Family Nurse Practitioner (Certified)
Internal Medicine - Pulmonary Disease
Doctor of Medicine (M.D.)
Career & Practice History
NPI enumerated May 05, 2008.
No changes to the name, practice address, taxonomy or NPI status in this record have been observed in the monthly NPPES data files from January 2017 to November 2026.
NPI Administrative Meta
Other Internal Medicine - Pulmonary Diseases in Nacogdoches
Healthcare providers in NacogdochesMailing Address
Po Box 631310
Nacogdoches, TX 759631310
Phone: 9365854646